GERCX
Price
$9.56
Change
-$0.01 (-0.10%)
Updated
Jun 18 closing price
Net Assets
2.36B
VEMIX
Price
$30.39
Change
-$0.10 (-0.33%)
Updated
Jun 18 closing price
Net Assets
116.44B
Interact to see
Advertisement

GERCX vs VEMIX

Header iconGERCX vs VEMIX Comparison
Open Charts GERCX vs VEMIXBanner chart's image
Goldman Sachs Em Mkts Eq Insghts C
Price$9.56
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets2.36B
Vanguard Emerging Mkts Stock Idx Instl
Price$30.39
Change-$0.10 (-0.33%)
VolumeN/A
Net Assets116.44B
GERCX vs VEMIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GERCX vs. VEMIX commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERCX is a Hold and VEMIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 116B vs. GERCX (2.36B). VEMIX pays higher dividends than GERCX: VEMIX (3.00) vs GERCX (0.19). GERCX was incepted earlier than VEMIX: GERCX (18 years) vs VEMIX (25 years). GERCX (2.26) is less costly to investors than VEMIX (0.09). GERCX is a more actively managed with annual turnover of: 168.00 vs. VEMIX (8.00). GERCX has a lower initial minimum investment than VEMIX: GERCX (1000) vs VEMIX (5000000). VEMIX annual gain was more profitable for investors over the last year : 10.97 vs. GERCX (8.00). VEMIX return over 5 years is better than : 33.07 vs. GERCX (14.70).
GERCXVEMIXGERCX / VEMIX
Total Expense Ratio2.090.092,322%
Annual Report Gross Expense Ratio2.260.092,511%
Fund Existence18 years25 years-
Gain YTD11.1638.763127%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRA250N/A-
Net Assets2.36B116B2%
Annual Yield % from dividends0.193.006%
Returns for 1 year8.0010.9773%
Returns for 3 years22.9625.1291%
Returns for 5 years14.7033.0744%
Returns for 10 years16.4738.0543%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGOAX38.700.49
+1.28%
Patient Opportunity A
ATHWX20.23N/A
N/A
American Century Heritage R
HLPPX9.90N/A
N/A
LDR Real Estate Value Opportunity P
WPGSX10.12N/A
N/A
WPG Partners Select Small Cap Value Ins
CAMLX46.65-0.18
-0.38%
Congress Large Cap Growth Retail